1. Home
  2. HAIN vs ELTX Comparison

HAIN vs ELTX Comparison

Compare HAIN & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hain Celestial Group Inc. (The)

HAIN

Hain Celestial Group Inc. (The)

HOLD

Current Price

$0.15

Market Cap

53.7M

ML Signal

HOLD

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

BUY

Current Price

$1.55

Market Cap

63.3M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
HAIN
ELTX
Founded
1993
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.7M
63.3M
IPO Year
1996
2014

Fundamental Metrics

Financial Performance
Metric
HAIN
ELTX
Price
$0.15
$1.55
Analyst Decision
Hold
Buy
Analyst Count
3
4
Target Price
$1.43
★ $13.67
AVG Volume (30 Days)
★ 2.0M
279.9K
Earning Date
11-09-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 42.95
39.29
EPS
N/A
★ N/A
Revenue
★ $2,457,769,000.00
$2,301,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$0.58
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.12
$1.44
52 Week High
$1.48
$16.00

Technical Indicators

Market Signals
Indicator
HAIN
ELTX
Relative Strength Index (RSI) 24.72 35.80
Support Level N/A $1.44
Resistance Level $0.64 $1.98
Average True Range (ATR) 0.05 0.20
MACD -0.00 0.00
Stochastic Oscillator 6.46 14.81

Price Performance

Historical Comparison
HAIN
ELTX

About HAIN Hain Celestial Group Inc. (The)

The Hain Celestial Group Inc is a health and wellness company. It makes natural and organic food and personal-care products. The company offers products across various categories such as snacks, baby & kids food, beverages, meal preparation, and personal care through brands like Garden Veggie Snacks, Terra chips, Garden of Eatin snacks, Hartley's Jelly, and Celestial Seasonings teas, among others. It operates under two reportable segments: North America and International. The majority of its revenue is derived from the North America segment, which represents the sale of its products in the United States and Canada. The International segment includes the sale of its products in the United Kingdom and the Western European region.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.

Share on Social Networks: